Theriva Biologics, Inc. (TOVX) stock analysis and AI prediction
The company facts of Theriva Biologics, Inc., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Theriva Biologics, Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
- Sector
- Healthcare
- Exchange
- AMEX
- Market value
- $7.3 million
- Size
- Micro cap
- Employees
- 16
- Headquarters
- ROCKVILLE, MD
- Listed since
- April 5, 1993
- Website
- therivabio.com
More Healthcare stocks
Other micro cap stocks
Keep going
TOVX questions
What is the AI prediction for TOVX stock?
Each market day our model rates Theriva Biologics, Inc. (TOVX) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the TOVX prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for TOVX?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see TOVX options?
The TOVX options page opens its calls and puts, with price, volume, implied volatility and the Greeks.